BCG Vaccines Sales Market to growing at CAGR of 4.2% by 2025, Top Prominent Players: Intervax Ltd, Japan BCG Laboratory

Rise in prevalence of tuberculosis worldwide and surge in the number of drug-resistant tuberculosis cases propel the growth of the global BCG vaccines sales market

The global BCG vaccines sales market accounted for $45.5 million in 2017 and is expected to reach $65.9 million by 2025, growing at a CAGR of 4.2% during the forecast period, 2018-2025.

Download Detailed COVID-19 Impact Sample Report at @ https://www.alliedmarketresearch.com/request-for-customization/2604?reqfor=covid

COVID-19 scenario-

1) Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production including ventilators and diagnostics.

2) However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations.

3) Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to notify the agency about changes that could affect availability of their products.

Surge in prevalence of tuberculosis around the globe and increase in the number of drug-resistant tuberculosis cases drive the growth of the global BCG vaccines sales market. Additionally, rise in initiatives by the United Nations (UN) to prevent tuberculosis would present lucrative opportunities for emerging market players in the near future. However, technological advancements aiding the development of BCG vaccine replacement impede market growth.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2604

Immune BCG segment to continue its dominance in the near future

By drug type, the immune BCG segment occupied more than 90% of the overall market in 2017 and is expected to continue the trend through 2025. The segment is also poised to register the highest CAGR of 4.9% during the forecast period, due to lack of substitutes that provide immaculate immunity against tuberculosis.

Tuberculosis segment to register the highest growth rate from 2018 to 2025

By usage, the tuberculosis segment is projected to grow at the highest CAGR of 5.0% during the forecast period and occupy more than four-fifths of the overall market by 2025. This is attributed to the high prevalence of tuberculosis and a large number of associated deaths globally.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/2604

Pediatrics segment to generate the largest revenue through 2025

By end user, the pediatrics segment is expected to continue its market dominance in the future and generate nearly four-fifths of the global revenue by 2025. This is due to high-effectiveness of BCG vaccines in children to prevent the onset of tuberculosis. The segment is also projected to register the highest CAGR of 6.0% during the forecast period.

Asia-Pacific to occupy the largest share in the forecast period

Asia-Pacific is expected to occupy more than two-thirds of the overall market shares by 2025, due to increased demand in low-level income population, i.e. India, to prevent tuberculosis epidemic. Meanwhile, the region of Latin America, the Middle East, and Africa (LAMEA) is projected to grow at the highest CAGR of 5.3% due to increased awareness and higher disposable income of consumers.

To know more about the report, visit the website at @ https://www.alliedmarketresearch.com/bcg-vaccine-sales-market

The Major Key Players Are:

AJ Vaccines, China National Pharmaceutical Group Corporation (Sinopharm), Greensignal Bio Pharma Limited, Intervax Ltd, Japan BCG Laboratory, Merck & Company Inc, Sanofi S.A., Serum Institute of India Pvt. Ltd., and Statens Serum Institute.

Similar Reports:

IVF Services Market : https://www.pharmiweb.com/press-release/2020-09-18/ivf-services-market-growing-at-cagr-of-93-and-to-target-256-billion-by-2026

IVF Devices and Consumables Market : https://www.pharmiweb.com/press-release/2020-09-18/ivf-devices-and-consumables-market-to-see-record-break-revenue-773-billion-by-2026

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.